Literature DB >> 15588704

Inactivation of parasite cysteine proteinases by the NO-donor 4-(phenylsulfonyl)-3-((2-(dimethylamino)ethyl)thio)-furoxan oxalate.

Paolo Ascenzi1, Alessio Bocedi, Marco Gentile, Paolo Visca, Luigi Gradoni.   

Abstract

NO-donors block Plasmodium, Trypanosoma, and Leishmania life cycle by inactivating parasite enzymes, e.g., cysteine proteinases. In this study, the inactivation of falcipain, cruzipain, and Leishmania infantum cysteine proteinase by the NO-donor 4-(phenylsulfonyl)-3-((2-(dimethylamino)ethyl)thio)-furoxan oxalate (SNO-102) is reported. SNO-102 inactivates dose- and time-dependently parasite cysteine proteinases; one equivalent of NO, released from SNO-102, inactivates one equivalent of L. infantum cysteine proteinase. With SNO-102 in excess over the parasite cysteine proteinase, the time course of enzyme inhibition corresponds to a pseudo-first-order reaction for more than 90% of its course. The concentration dependence of the pseudo-first-order rate constant is second-order at low SNO-102 concentration but tends to first-order at high NO-donor concentration. This behavior may be explained by a relatively fast pre-equilibrium followed by a limiting pseudo-first order process. Kinetic parameters of L. infantum cysteine proteinase inactivation by SNO-102 are affected by the acidic pK shift of one apparent ionizing group (from pK(unl)=5.8 to pK(lig)=4.7) upon enzyme inhibition. Falcipain, cruzipain and L. infantum cysteine proteinase inactivation is prevented and reversed by dithiothreitol and L-ascorbic acid. Furthermore, the fluorogenic substrate N-alpha-benzyloxycarbonyl-Phe-Arg-(7-amino-4-methylcoumarin) protects parasite cysteine proteinases from inactivation by SNO-102. The absorption spectrum of the inactive S-nitrosylated SNO-102-treated L. infantum cysteine proteinase displays a maximum at about 340 nm. These results indicate that the parasite cysteine proteinase inactivation by SNO-102 occurs via the NO-mediated S-nitrosylation of the Cys25 catalytic residue.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15588704     DOI: 10.1016/j.bbapap.2004.09.027

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Furoxans (1,2,5-oxadiazole-N-oxides) as novel NO mimetic neuroprotective and procognitive agents.

Authors:  Isaac T Schiefer; Lawren VandeVrede; Mauro Fa'; Ottavio Arancio; Gregory R J Thatcher
Journal:  J Med Chem       Date:  2012-03-30       Impact factor: 7.446

2.  Calcium-dependent proteolytic activity of a cysteine protease caldonopain is detected during Leishmania infection.

Authors:  Runu Dey; Jharna Bhattacharya; Salil C Datta
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

3.  Aziridine-2,3-dicarboxylates, peptidomimetic cysteine protease inhibitors with antileishmanial activity.

Authors:  Alicia Ponte-Sucre; Radim Vicik; Martina Schultheis; Tanja Schirmeister; Heidrun Moll
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

4.  Reactions of HNO with heme proteins: new routes to HNO-heme complexes and insight into physiological effects.

Authors:  Murugaeson R Kumar; Jon M Fukuto; Katrina M Miranda; Patrick J Farmer
Journal:  Inorg Chem       Date:  2010-07-19       Impact factor: 5.165

5.  The trypanocidal effect of NO-releasing agents is not due to inhibition of the major cysteine proteinase in Trypanosoma brucei.

Authors:  Dietmar Steverding; Xia Wang; Darren W Sexton
Journal:  Parasitol Res       Date:  2009-07-16       Impact factor: 2.289

6.  Nitro/nitrosyl-ruthenium complexes are potent and selective anti-Trypanosoma cruzi agents causing autophagy and necrotic parasite death.

Authors:  Tanira M Bastos; Marília I F Barbosa; Monize M da Silva; José W da C Júnior; Cássio S Meira; Elisalva T Guimaraes; Javier Ellena; Diogo R M Moreira; Alzir A Batista; Milena B P Soares
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

7.  Leishmanicidal activities of novel synthetic furoxan and benzofuroxan derivatives.

Authors:  Luiz Antônio Dutra; Letícia de Almeida; Thais G Passalacqua; Juliana Santana Reis; Fabio A E Torres; Isabel Martinez; Rosangela Gonçalves Peccinini; Chung Man Chin; Konstantin Chegaev; Stefano Guglielmo; Roberta Fruttero; Marcia A S Graminha; Jean Leandro dos Santos
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

8.  Leishmania amazonensis amastigotes highly express a tryparedoxin peroxidase isoform that increases parasite resistance to macrophage antimicrobial defenses and fosters parasite virulence.

Authors:  Calvin A Henard; Eric D Carlsen; Christie Hay; Peter E Kima; Lynn Soong
Journal:  PLoS Negl Trop Dis       Date:  2014-07-17

9.  Design, synthesis and biological evaluation of N-oxide derivatives with potent in vivo antileishmanial activity.

Authors:  Leandro da Costa Clementino; Guilherme Felipe Santos Fernandes; Igor Muccilo Prokopczyk; Wilquer Castro Laurindo; Danyelle Toyama; Bruno Pereira Motta; Amanda Martins Baviera; Flávio Henrique-Silva; Jean Leandro Dos Santos; Marcia A S Graminha
Journal:  PLoS One       Date:  2021-11-01       Impact factor: 3.240

10.  Stress Induces Release of Extracellular Vesicles by Trypanosoma cruzi Trypomastigotes.

Authors:  Camilla Ioshida Vasconcelos; A Cronemberger-Andrade; Normanda Souza-Melo; Juliana Terzi Maricato; Patrícia Xander; Wagner Luiz Batista; Rodrigo Pedro Soares; Sergio Schenkman; Ana Claudia Torrecilhas
Journal:  J Immunol Res       Date:  2021-09-23       Impact factor: 4.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.